ADCY1 and cardiac hypertrophy: Catecholamine-induced cardiac hypertrophy and failure is associated with reduced contractile response to adrenergic agonists, an effect attributed to the down regulation of myocardial β-ARs, uncoupling of β-ARs and adenylate cyclase, as well as modifications of downstream cAMP-mediated signaling.